Brain Markers of Suicide Risk and Psychological Pain in Elderly Depressed Patients
NCT ID: NCT03287986
Last Updated: 2020-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2017-08-18
2019-12-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain, Reward, Attention and Neurocircuitry: Biomarkers of Suicidality
NCT02811198
Emotional Prosody Recognition and Decision Making Inf fMRI and Vulnerability to Suicide
NCT02901769
Using Functional MRI Neurofeedback to Modulate Self-blame in Major Depressive Disorder
NCT05455827
Cognitive, Psychological and Electrophysiological Attributes to Suicide Among Depressed Patients
NCT04104698
Exploration of Differences in Metabolite Concentrations by NMR Spectroscopy in the Ventral Striatum, Anterior Cingulate Cortex and Prefrontal Cortex in Euthymic Patients With Unipolar and Bipolar Type II Mood Disorders, as Well as in Healthy Subjects
NCT05650788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suicide attempters
Depressed patients over 60 years of age with a personal history of suicide attempts scanned with MRI
MRI
Structural and functional sequences
Patient controls
depressed patients over 60 years of age without a personal history of suicide attempt scanned with MRI
MRI
Structural and functional sequences
Healthy Controls
Healthy subjects over 60 years, not depressed and without personal history of severe mental illness or suicide attempts, scanned with MRI
MRI
Structural and functional sequences
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
Structural and functional sequences
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be a member or beneficiary of a health insurance plan
* aged 60 years-old or more
* must be right-handed
* with a diagnosis of a current major depressive episode of moderate to severe severity according to diagnostic criteria.
* with or without a personal history of attempted suicide during life
* hospitalized or followed by a consultant in the department of Psychiatry of Nîmes University Hospital or in the Sophoras private clinic
Exclusion Criteria
* under safeguard of justice
* refuses to sign the consent
* It is impossible to give the subject informed information
* Current psychotic symptoms.
* Bipolar disorder.
* The subject presents an acute somatic decompensation incompatible with the realization of this study.
* The patient presents a mental confusion or a known Mini Mental State Examination score \<24.
* Central neurological disease known in particular degenerative pathology, severe cranial trauma and severe cerebrovascular disease.
* Schizophrenia and other known psychotic disorders.
* Electroconvulsive therapy in the 12 months prior to study
* Inability to perform neuropsychological tests because of a language problem, poor understanding, a major tremor, inability to sit still, a major sight problem that cannot be corrected, or other severe cognitive impairment
* Contra-indication to magnetic resonance imaging (MRI): ferromagnetic implant in the body, piercing, claustrophobia, inability to remain elongated for 45 minutes.
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabrice Jollant, MD PhD
Role: PRINCIPAL_INVESTIGATOR
CHU Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LOCAL/2016/FJMW-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.